Novartis has inked a deal with UK biotech Relation to discover and develop new drugs for certain immune diseases.
This is the second deal with a large pharmaceutical company for Relation, which previously
Tenaya Therapeutics, a company focused on developing gene therapies for heart conditions, made a series of announcements on Thursday. The biotech said the FDA has
The FDA on Thursday expanded the label for Amgen’s rare disease drug Uplizna, approving it in an autoimmune disorder that’s quickly become a hot —
→ Centessa Pharmaceuticals president Mario Alberto Accardi will take over as CEO on Jan. 1. Saurabh Saha has held the top spot since its splashy
GSK’s RSV vaccine is poised for EU approval in all adults aged 18 and over, bringing it into line with rival shots from Pfizer and
A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.
Novartis has inked a deal with UK biotech Relation to discover and develop new drugs for certain immune diseases.
This is the second deal with a large pharmaceutical company for Relation, which previously